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Background
The accumulation of somatic mutation is a common
property in all cancer genomes. These mutations include
several patterns of mutagenesis such as small insertions,
chromosomal rearrangement and nucleotide substitu-
tions. Consequently, the mutated genomes produce
mutant transcriptome and, therefore, mutant proteins
that give the cancer cell its oncogenic properties [1]. For
such mutated proteins, however, mass spectrometry-
based identification by shotgun proteomics is generally
difficult because the identification is dependent on data-
bases containing normal proteins or hybrid database
with normal and mutated proteins. Here, we present
‘onco-proteogenomics, a novel proteogenomics approach
to identify the cancer-related peptides (phospho- and
non-phospho peptides) and proteins.
Methods
We analyzed 15 MS/MS runs of HeLa S3 cells, as a test
sample, by shotgun proteomics and phosphoproteomics.
The obtained data was analyzed by an extended version
of MSSS (MS Spectra Sequential Subtraction), the pro-
teogenomic approach that we used before in the identi-
fication of novel genomic features in Rice plant [2]. In
our onco- proteogenomic approach, we used four data-
bases containing normal sequences (Human protein,
cDNA, mRNA and genome databases) for Mascot pep-
tide identification and removed all the MS/MS spectra
that corresponds to all identified peptides. The reminder
MS/MS spectra were searched against one cancer-driven
database obtained through deep sequencing of HeLa S3
cells to identify cancer-specific peptides.
Results
The four databases that contain normal sequences
were used sequentially to identify all potential peptide
sequences and phosphorylation sites that can be gener-
ated from the normal genome. This includes the
potential protein sequences, junction-peptides and
exon-skipping peptides (protein and cDNA databases),
exonic peptides (mRNA database) and extragenic
peptides (genome database). Following each Mascot
search, we removed all the MS/ MS spectra corre-
sponding to the identified peptide sequences and
created new files containing the reminder MS/MS
spectra. Next, we constructed HeLa S3 transcriptome
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Figure 1 Analysis flowchart and future work.
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© 2010 Helmy et al; licensee BioMed Central Ltd.database with data obtained from deep sequencing of
HeLa S3 cells (obtained from NCBI UniGene Data-
base). The constructed database contains over 60,000
entries. For the remaining unidentified MS/MS spectra,
we performed Mascot search against this transcriptome
database. Consequently, we were able to identify 25
cancer-specific peptides including phosphorylated sites.
For further check, the identified peptides were aligned
to the employed normal databases using NCBI BLAST.
The alignment did not show any significant matches
indicating that these peptides are specifically expressed
in the HeLa S3 cancer cell-line. In future studies, we
will apply the same approach in different cancers aim-
ing to identify global cancer biomarkers and drug tar-
gets Figure 1.
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